UAE deploys AI and genomics to predict chronic disease risks Early

The UAE healthcare system transitioned to a proactive predictive model on Monday, 17 August, integrating artificial intelligence, genomics, and big data to detect medical risks before they develop into chronic diseases. Genomics and Newborn Screening A central component of the new strategy is Abu Dhabi’s newborn genetic screening programme. The initiative now enables the early detection of 815 treatable genetic conditions, many of which are asymptomatic at birth but pose long-term health risks. Furthermore, premarital screening protocols have been expanded to cover 570 genes associated with more than 840 medical conditions, according to health officials. Precision medicine is also being deployed through pharmacogenomic technologies. These tools allow physicians to select medications and dosages specifically tailored to a patient’s genetic profile, reducing the risk of adverse reactions and improving treatment efficacy for complex cases. AI Integration in Clinical Care Artificial intelligence applications have been deployed across nationwide facilities to monitor critical conditions. These include smart warning systems designed to predict sepsis and septic shock before clinical symptoms appear. Other AI-driven tools now in use include technologies for forecasting epileptic seizures in children, predicting pregnancy complications, and monitoring premature infants. The Ministry of Health and Prevention and regional health authorities are also utilizing the "Behavioural…